Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,132

Active & Responsive

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

for

Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 10+

Code: NCT04199026

Recruiting

Active & Responsive

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

for

Cell Therapy

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06575374

Phase 2, Recruiting

Active & Responsive

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for

Ovarian Cancer, Fallopian Tube Cancer

Location: Houston TX, St Louis MO, Chicago IL, Rochester MN,

Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05287451

Recruiting

Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for

Metastatic Dedifferentiated Liposarcoma,

Location: Houston TX, Oklahoma City OK, Nashville TN, St Louis MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase 3, Recruiting

Active & Responsive

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

for

HPV

Location: Houston TX, Austin TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06109870

Recruiting

Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for

PIK3CA Mutation, Solid Tumor, Adult,

Location: Houston TX, Dallas TX, Nashville TN, St Louis MO,

Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase 1, Recruiting

Active & Responsive

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

for

Surgery-Complications, Anesthesia Complication,

Location: Houston TX, Dallas TX, Little Rock AR, St Louis MO,

Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05991453

Recruiting

Active & Responsive

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for

Autoimmune Disease, Crohn Disease, Dermatomyositis,

Location: Houston TX, Dallas TX, Fort Worth TX, Richardson TX,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03816345

Phase 1, Recruiting

Active & Responsive

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

for

Advanced Solid Tumors, Genital Neoplasm, Female,

Location: Houston TX, San Antonio TX, Kansas City KS,

Sponsor: Marengo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05592626

Phase 1, Phase 2, Recruiting

Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for

Metastatic Head and Neck Squamous Cell Carcinoma,

Location: Houston TX, Waco TX, Birmingham AL, Westwood KS,

Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase 2, Phase 3, Recruiting

Active & Responsive

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for

Myelofibrosis; Anemia, Anemia, Myelofibrosis,

Location: Houston TX, Temple TX, St Louis MO, Atlanta GA,

Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT05320198

Phase 1, Phase 2, Recruiting

Active & Responsive

Use of Nicotine Pouches Among Daily Smokers

for

Tobacco Dependence

Location: Houston TX, Hershey PA

Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 21 - 70

Code: NCT06043362

Recruiting

Active & ResponsiveNew

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

for

Melanoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07444606

Phase 1, Recruiting

Active & ResponsiveNew

First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer

for

Pancreatic Cancer, Pancreatic Acinar Carcinoma

Location: Houston TX

Sponsor: ParVation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07756281

Phase 1, Recruiting

Active & ResponsiveNew

A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

for

Advanced Solid Tumors

Location: Houston TX, San Antonio TX, Fort Worth TX,

Sponsor: Antares Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT07767474

Phase 1, Phase 2, Recruiting

Active & Responsive

Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions

for

Premalignant Lesion

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06561087

Phase 2, Recruiting

Active & Responsive

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

for

Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma

Location: Houston TX, Oklahoma City OK, Nashville TN,

Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05431270

Phase 1, Phase 2, Recruiting

Active & Responsive

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for

Solid Tumor Malignancies, Brain Metastases From Solid Tumors

Location: Houston TX, Dallas TX, Oklahoma City OK, Charleston SC,

Sponsor: A2A Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06136884

Phase 1, Recruiting

Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for

Cancer, Colorectal Cancer, Solid Tumor,

Location: Houston TX, San Antonio TX, Nashville TN, St Louis MO,

Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase 1, Phase 2, Recruiting

Active & Responsive

Study of REM-422 in Patients With AML or Higher Risk MDS

for

Myelodysplastic Syndromes,

Location: Houston TX, Tampa FL, Duarte CA, New York NY, Boston MA

Sponsor: Remix Therapeutics

Sex: All

Age: 18+

Code: NCT06297941

Phase 1, Recruiting

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City

Paid Clinical Trials Houston

Filter results

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

Interested in new trials?

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Use of Nicotine Pouches Among Daily Smokers

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer

A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Study of REM-422 in Patients With AML or Higher Risk MDS